Socioeconomic status (SES) and childhood acute myeloid leukemia (AML) mortality risk: Analysis of SEER data

被引:25
|
作者
Knoble, Naomi B. [1 ]
Alderfer, Melissa A. [1 ,2 ]
Hossain, Md Jobayer [3 ,4 ]
机构
[1] Alfred I DuPont Hosp Children, Ctr Healthcare Delivery Sci, Nemours Biomed Res, Wilmington, DE 19803 USA
[2] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Pediat, Philadelphia, PA 19107 USA
[3] Alfred I DuPont Hosp Children, Nemours Biomed Res, Biostat Core, Wilmington, DE 19803 USA
[4] Univ Delaware, Dept Appl Econ & Stat, Newark, DE 19716 USA
基金
美国国家卫生研究院;
关键词
Pediatrics; Acute myeloid leukemia; Mortality; Social class; Immigrants; Residential mobility; HEALTH-CARE; RESIDENTIAL-MOBILITY; SURVIVAL; CANCER; DISPARITIES; US; ASSOCIATION; REMOTENESS;
D O I
10.1016/j.canep.2016.07.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Socioeconomic status (SES) is a complex construct of multiple indicators, known to impact cancer outcomes, but has not been adequately examined among pediatric AML patients. This study aimed to identify the patterns of co-occurrence of multiple community-level SES indicators and to explore associations between various patterns of these indicators and pediatric AML mortality risk. A nationally representative US sample of 3651 pediatric AML patients, aged 0-19 years at diagnosis was drawn from 17 Surveillance, Epidemiology, and End Results (SEER) database registries created between 1973 and 2012. Factor analysis, cluster analysis, stratified univariable and multivariable Cox proportional hazards models were used. Four SES factors accounting for 87% of the variance in SES indicators were identified: F1) economic/educational disadvantage, less immigration; F2) immigration-related features (foreign-born, language-isolation, crowding), less mobility; F3) housing instability; and, F4) absence of moving. F1 and F3 showed elevated risk of mortality, adjusted hazards ratios (aHR) (95% CI): 1.07(1.02-1.12) and 1.05(1.00-1.10), respectively. Seven SES-defined cluster groups were identified. Cluster 1 (low economic/ educational disadvantage, few immigration-related features, and residential-stability) showed the minimum risk of mortality. Compared to Cluster 1, Cluster 3 (high economic/educational disadvantage, high-mobility) and Cluster 6 (moderately-high economic/educational disadvantages, housing-instability and immigration-related features) exhibited substantially greater risk of mortality, aHR(95% CI) = 1.19 (1.0-1.4) and 1.23 (1.1-1.5), respectively. Factors of correlated SES-indicators and their pattern-based groups demonstrated differential risks in the pediatric AML mortality indicating the need of special public-health attention in areas with economic-educational disadvantages, housing-instability and immigration-related features. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:101 / 108
页数:8
相关论文
共 50 条
  • [41] Prognostic nomogram for adult patients with acute myeloid leukemia A SEER database analysis
    Chen, Cunte
    Wang, Peipei
    Wang, Caixia
    MEDICINE, 2019, 98 (21)
  • [42] High-throughput mutation analysis in acute myeloid leukemia (AML)
    Dunlap, J.
    Corless, C. L.
    Fleming, W. H.
    Braziel, R.
    Leeborg, N.
    Gatter, K.
    Loriaux, M.
    Kelemen, K.
    Kovacsovics, T.
    Fan, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [43] Perceptions of prognosis and treatment risk in older patients with acute myeloid leukemia (AML).
    Nicholson, Showly
    Abel, Gregory A.
    Fathi, Amir Tahmasb
    Steensma, David P.
    LeBlanc, Thomas William
    DeAngelo, Daniel J.
    Wadleigh, Martha
    Hobbs, Gabriela
    Foster, Julia
    Brunner, Andrew Mark
    Amrein, Philip C.
    Stone, Richard M.
    Temel, Jennifer S.
    El-Jawahri, Areej
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (31)
  • [44] Validation of the 2022 European Leukemianet Risk Stratification of Acute Myeloid Leukemia (AML)
    Biswas, Seema
    Achrekar, Aarti Ramesh
    Ugale, Priyanka Rajesh
    Joshi, Swapnali
    Terse, Vishram
    Shetty, Dhanlaxmi Lalit
    Jindal, Nishant
    Tembhare, Prashant
    Mirgh, Sumeet
    Shetty, Alok
    Gokarn, Anant
    Punatar, Sachin
    Nayak, Lingaraj
    Jain, Hasmukh
    Sengar, Manju
    Khattry, Navin
    Bagal, Bhausaheb
    Rajpal, Sweta
    Chatterjee, Gaurav
    Subramanian, Pg
    Gujral, Sumeet
    Patkar, Nikhil
    BLOOD, 2024, 144 : 4310 - 4311
  • [45] GENOMIC CHARACTERIZATION OF PATIENTS WITH LOW-RISK ACUTE MYELOID LEUKEMIA (AML)
    Prieto-Conde, M. I.
    Jimenez, C.
    Alcoceba, M.
    Garcia-Alvarez, M.
    Sarasquete, M. E.
    Balanzategui, A.
    Hernandez-Ruano, M.
    Sebastian, E.
    Corral, R.
    Marn, L.
    Ramos, F.
    Godoy, A.
    Barez, A.
    Gutierrez, N. C.
    Garcia-Sanz, R.
    Gonzalez-Diaz, M.
    Chillon, M. C.
    HAEMATOLOGICA, 2016, 101 : 668 - 668
  • [46] A Personalized Prediction Model to Risk Stratify Patients with Acute Myeloid Leukemia (AML)
    Nazha, Aziz
    Mukherjee, Sudipto
    Al-Issa, Karam
    Makhoul, Ahed
    Adema, Vera
    Hirsch, Cassandra M.
    Advani, Anjali S.
    Gerds, Aaron T.
    Kalaycio, Matt
    Carraway, Hetty E.
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    BLOOD, 2017, 130
  • [47] Early mortality risk with non-intensive acute myeloid leukemia (AML) therapies: analysis of 1336 patients from MRC/NCRI and SWOG
    Othus, Megan
    Thomas, Ian
    Wang, Xu
    Ariti, Cono
    Mehta, Priyanka
    Sydenham, Mia
    Hills, Robert K.
    Burnett, Alan K.
    Nand, Sucha
    Assouline, Sarit
    Michaelis, Laura C.
    Erba, Harry P.
    Russell, Nigel
    Kerr, Kathleen F.
    Walter, Roland B.
    Dennis, Mike
    LEUKEMIA & LYMPHOMA, 2023, 64 (01) : 250 - 252
  • [48] Association between Cytogenetic Risk and Obesity in Patients with Acute Myeloid Leukemia (AML): A Meta-Analysis
    Benkhadra, Raed
    Kovalenko, Iuliia
    Proskuriakova, Ekaterina
    Nayfeh, Tarek
    Auster, Michael
    Hassett, Leslie
    Kaur, Supreet
    BLOOD, 2023, 142
  • [49] Assessment of circulating biochemical markers and antioxidative status in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) patients
    Rasool, Mahmood
    Farooq, Shahzad
    Malik, Arif
    Shaukat, Aysha
    Manan, Abdul
    Asif, Muhammad
    Sani, Suleman
    Qazi, Mahmood Husain
    Kamal, Mohammad Amjad
    Iqbal, Zafar
    Hussain, Abrar
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2015, 22 (01) : 106 - 111
  • [50] Socioeconomic status and childhood acute lymphocytic leukemia incidence in Sao Paulo, Brazil
    Ribeiro, Karina Braga
    Buffler, Patricia A.
    Metayer, Catherine
    INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (08) : 1907 - 1912